A Phase 2, Randomized, 3-Arm Study of Abiraterone Acetate alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix alone for Patients with Prostate Cancer with a Rise PSA or a Rising PSA and Nodal Disease Following Definitive ...